Related Experiment Video
Updated: Apr 29, 2026

Design and Development of a Model to Study the Effect of Supplemental Oxygen on the Cystic Fibrosis Airway Microbiome
Published on: August 3, 2021
Extracorporeal membrane oxygenation (ECMO) in cystic fibrosis
Nimish Shah1, Felicity Perrin1
1King's College Hospital, London.
Abstract:
Extracorporeal membrane oxygenation (ECMO) is a potential form of therapy in cystic fibrosis. We discuss this form of treatment, particularly in relation to respiratory failure secondary to influenza in a patient with cystic fibrosis whose condition deteriorated post partum.
Related Concept Videos
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Acute Respiratory Failure-III
Extracorporeal Removal of Drugs: Hemoperfusion and Hemofiltration
Assessment of Diffusion and Perfusion
The Role of Diffusion in Respiration
Diffusion is the process by which molecules move from an area of higher concentration to an area of lower concentration. In the respiratory system, this...
Oxygen Delivering System II: Venturi Mask and Transtracheal Oxygen
Venturi Mask
The Venturi mask, named after the Venturi effect, is designed to deliver precise oxygen concentrations. It consists of a large tube with an oxygen inlet that narrows down, causing a pressure drop that pulls air in through adjustable side ports. The mask is a lightweight,...

